Иващенко Андрей Александрович (RU);Савчук Николай Филиппович (RU);Иващенко Александр Васильевич (RU)
发明人:
Иващенко Александр Васильевич (RU),Бычко Вадим Васильевич (US),Ткаченко Сергей Евгеньевич (US)
申请号：
RU2011143086/15
公开号：
RU2011143086A
申请日:
2011.10.26
申请国别(地区):
RU
年份:
2013
代理人:
摘要：
1. A pharmaceutical composition in the form of capsule tablets or injections in an acceptable package for the treatment of diseases caused by bacterial and nosocomial infections, comprising Rifamycin and an interferon inducer in pharmacologically effective doses. The pharmaceutical composition according to claim 1, comprising rifampicin as rifamycin. 3. The pharmaceutical composition according to claim 1, comprising Rifalazil as rifamycin. 4. The pharmaceutical composition according to claim 1, comprising rifampicin as rifamycin and cycloferon as an interferon inducer. 5. The pharmaceutical composition according to claim 1, comprising Rifalazil as rifamycin and Cycloferon as an interferon inducer. The pharmaceutical composition according to claim 1, comprising Cycloferon, Larifan, Amiksin, Hyporamine, Bropirimin, Imiquimod, Rezikimod or IMO-2125.7 as an interferon inducer. A pharmaceutical kit in an acceptable package for the treatment of diseases caused by bacterial and nosocomial infections, including, in pharmacologically effective doses, Rifamycin in the form of capsule or injection tablets, an interferon inducer in the form of capsule or injection tablets and instructions for administering the components of this pharmaceutical kit. 8. The pharmaceutical kit according to claim 7, intended for the treatment of diseases caused by Mycobacterium tuberculosis, Mycobacterium avium complex, Chlamydia pneumoniae, Chlamydia trachomatis, Helicobacter pylory and nosocomial infections. The pharmaceutical kit according to claim 7, comprising Rifampicin or Rifalazil as rifamycin. The pharmaceutical kit according to claim 7, comprising Cycloferon, Larifan, Amiksin, Hyporami as an interferon inducer1. Фармацевтическая композиция в виде таблеток капсул или инъекций, помещенных в приемлемую упаковку, для лечения заболеваний обусловленных бактериальными и внутрибольничными инфекциями, включающая Рифамицин и индуктор интерферона в фармакологически эффективных дозах.2. Фармацевтичес
